CLINICAL_TRIALS
trial_result
· 2021-02-04
Clinical Trial Update: Tanezumab and Nerve Function In Arthritis Patients [Phase 3]
Summary
Phase 3 trial update for tanezumab in osteoarthritis has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-02-04